Article
Prognostic value of KRAS mutation in patients undergoing pulmonary metastasectomy for colorectal cancer: A systematic review and meta-analysis.
Critical reviews in oncology/hematology - 1 Apr 2021
Huang Junfeng, Zang Qing, Wen Yaokai, Pan Zhe, Yao Zhiyuan, Huang Mingkai, Huang Jiongqiang, Chen Jingsong, Wang Rongchang
Abstract excerpt
BACKGROUND: The purpose of the study was to evaluate whether KRAS mutation could be an independent prognostic biomarker in patients undergoing pulmonary metastasectomy (PM) for colorectal cancer (CRC). METHODS: A systemic review was performed by searching online databases to identify studies reporting overall survival (OS) and recurrence free survival (RFS) of CRC patients undergoing PM. Pooled HRs were...
Topics
Join the communities discussing this publication.
